Home/Filings/4/0000899243-22-013365
4//SEC Filing

Zamirowski Justin 4

Accession 0000899243-22-013365

CIK 0001832415other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:45 PM ET

Size

5.6 KB

Accession

0000899243-22-013365

Insider Transaction Report

Form 4
Period: 2022-04-01
Zamirowski Justin
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-04-01+86,80086,800 total
    Exercise: $1.97Exp: 2032-03-31Common Stock (86,800 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 1/4 of the shares subject to the stock option on April 1, 2023 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on April 1, 2022.

Issuer

Better Therapeutics, Inc.

CIK 0001832415

Entity typeother

Related Parties

1
  • filerCIK 0001888814

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:45 PM ET
Size
5.6 KB